NEDAPLATIN for Cervix carcinoma: Side Effects & Safety Data
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
There are 28 adverse event reports in the FDA FAERS database where NEDAPLATIN was used for Cervix carcinoma.
Most Reported Side Effects for NEDAPLATIN
| Side Effect | Reports | % | Deaths | Hosp. |
|---|---|---|---|---|
| Myelosuppression | 272 | 36.9% | 9 | 151 |
| White blood cell count decreased | 61 | 8.3% | 0 | 27 |
| Thrombocytopenia | 51 | 6.9% | 9 | 7 |
| Off label use | 49 | 6.6% | 2 | 20 |
| Neutropenia | 45 | 6.1% | 5 | 3 |
| Neutrophil count decreased | 41 | 5.6% | 0 | 15 |
| Bone marrow failure | 35 | 4.7% | 4 | 10 |
| Gastrointestinal disorder | 35 | 4.7% | 1 | 4 |
| Platelet count decreased | 35 | 4.7% | 0 | 15 |
| Disease progression | 33 | 4.5% | 14 | 3 |
| Nausea | 30 | 4.1% | 4 | 6 |
| Anaemia | 29 | 3.9% | 6 | 11 |
| Febrile neutropenia | 27 | 3.7% | 10 | 6 |
| Diarrhoea | 26 | 3.5% | 6 | 7 |
| Vomiting | 26 | 3.5% | 3 | 5 |
Other Indications for NEDAPLATIN
Oesophageal carcinoma (92)
Lung neoplasm malignant (71)
Nasopharyngeal cancer (46)
Chemotherapy (36)
Germ cell cancer (25)
Lung adenocarcinoma (25)
Ovarian cancer (20)
Oesophageal squamous cell carcinoma (17)
Metastases to lymph nodes (15)
Squamous cell carcinoma (15)
Other Drugs Used for Cervix carcinoma
PACLITAXEL (1,061)
BEVACIZUMAB (1,017)
PEMBROLIZUMAB (791)
CARBOPLATIN (755)
CISPLATIN (685)
TISOTUMAB VEDOTIN-TFTV (163)
ATEZOLIZUMAB (157)
NIVOLUMAB (124)
GEMCITABINE (73)
IPILIMUMAB (66)